Sidley represented BioRender, a scientific communication platform with the mission of accelerating the world’s ability to learn, discover, and communicate science, in connection with a strategic investment from Dimension Capital that values the company at approximately $900 million. As part of the transaction, BioRender provided liquidity to its employees.
The Sidley team was led by Michael Podolny (Emerging Companies and Venture Capital), and included Chloe Kaufman and Celine Gruaz (Emerging Companies and Venture Capital); Nicholas Frey (Employee Benefits and Executive Compensation); and Jonathan Westreich (Tax).
Where the legal industry reads first.
Enjoyed this article? Get the biggest legal industry updates, deals, appointments, insights and expert interviews in your inbox, free.
No spam. Unsubscribe anytime.From Legal Desire
Is your firm the one being cited, or the one being skipped?
We ran the test. On several everyday legal questions, software companies are answering and law firms are not. We help firms fix that, and we build the technology behind the practice.
Lawyers and firms: get featured on Legal Desire
Share your deals, lateral moves, firm news and insights with 1M+ monthly readers: founders, law firm partners, general counsel and practising lawyers across the US, UK, EU and GCC.
Get featuredSubmit a press releaseThe advising firms, the named deal team, the value and the parties, with every other announced deal by the same firms and lawyers. Open the deal record
